Although the mortality for coronary artery bypass graft surgery has declined, some categories of patients are still recognized as being at greater risk. Because the mortality, even for most patients with risk factors, is less than 10%, evaluating this risk and any improvement arising from changing techniques requires thousands of cases. The need for these large patient numbers makes the evaluation of changes difficult. Even when other risk factors are accounted for in the mortality estimate, the patient's age remains an important factor, although there is no obvious reason why this should be so. Similarly, female sex is well recognized as a risk factor. However, the tendency for women to have a smaller body surface area and corresponding smaller arterial diameters may be the explanation. Perfusion time appears to have a strong influence on mortality after it exceeds about 90 minutes, and a similar influence on myocardial infarction also appears to be present. The increased risk of myocardial infarction with unstable angina may relate to disruption of the normal endothelial vasodilatation caused by nitric oxide.

Download full-text PDF

Source

Publication Analysis

Top Keywords

myocardial infarction
12
coronary artery
8
artery bypass
8
risk factors
8
risk
6
mortality
5
factors influencing
4
influencing mortality
4
mortality myocardial
4
infarction coronary
4

Similar Publications

Background: He's team have recently developed a new Coronary Artery Tree description and Lesion EvaluaTion (CatLet) angiographic scoring system, which is capable of accounting for the variability in coronary anatomy, and risk-stratifying patients with coronary artery disease. Preliminary studies have demonstrated its superiority over the the Synergy between percutaneous coronary intervention with Taxus and Cardiac Surgery (SYNTAX) score with respect to outcome predictions for acute myocardial infarction (AMI) patients. However, there are fewer studies on the prognostic in chronic coronary artery disease(CAD).

View Article and Find Full Text PDF

Background: Myocardial infarction (MI) remains a leading cause of mortality globally, often resulting in irreversible damage to cardiomyocytes. Ferroptosis, a recently identified form of regulated cell death driven by iron-dependent lipid peroxidation, has emerged as a significant contributor to post-MI cardiac injury. The endoplasmic reticulum (ER) stress response has been implicated in exacerbating ferroptosis.

View Article and Find Full Text PDF

Myocardial infarction is a condition where the heart muscle is damaged due to clogged coronary arteries. There are limited treatment options for treating myocardial infarction. Microneedle patches have recently become popular as a possibly viable therapy for myocardial.

View Article and Find Full Text PDF

Cardiomyocytes can be implanted to remuscularize the failing heart. Challenges include sufficient cardiomyocyte retention for a sustainable therapeutic impact without intolerable side effects, such as arrhythmia and tumour growth. We investigated the hypothesis that epicardial engineered heart muscle (EHM) allografts from induced pluripotent stem cell-derived cardiomyocytes and stromal cells structurally and functionally remuscularize the chronically failing heart without limiting side effects in rhesus macaques.

View Article and Find Full Text PDF

Acute myocardial infarction (AMI) remains one of the most common causes for cardiogenic shock (CS), with high inpatient mortality (40-50 %). Studies have reported the use of pulmonary artery catheters (PACs) in decompensated heart failure, but contemporary data on their use to guide management of AMI-CS and in different SCAI stages of CS are lacking. We investigated the association of PACs and clinical outcomes in AMI-CS.

View Article and Find Full Text PDF

Want AI Summaries of new PubMed Abstracts delivered to your In-box?

Enter search terms and have AI summaries delivered each week - change queries or unsubscribe any time!